Cargando…

Persistent pruritus after hydroxyethyl starch (HES) infusions in critically ill patients

Detalles Bibliográficos
Autores principales:	Sharland, C, Huggett, A, Nielsen, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301851/ http://dx.doi.org/10.1186/cc523

Ejemplares similares

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Extracellular fluid variations during a fluid challenge: a comparison of normal saline (NS) and hydroxyethyl starch (HES) in stressed patients
por: Singer, P, et al.
Publicado: (1999)

Large volume resuscitation with hydroxyethyl starch (HES) in lactated Ringer's (LR) solution restores perfusion, minimally induces hyperchloremia or impairs coagulation
por: Kaplan, LJ, et al.
Publicado: (2001)

The variation of volume expansion after infusion of hydroxy ethyl starch 6% in critically ill patients
por: Anderson, J, et al.
Publicado: (1997)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

Hydroxyethyl Starch Related Pruritus: Neurophysiological Exploration
por: Brenaut, Emilie, et al.
Publicado: (2014)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Use of hydroxyethyl starch in critically ill patients
por: Bugedo, Guillermo, et al.
Publicado: (2013)

Cardiovascular function during acute normovolemic hemodilution (ANH) with hydroxyethyl starch or Ringer's lactate
por: Fraga, AO, et al.
Publicado: (2001)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Conjugates of methylated cyclodextrin derivatives and hydroxyethyl starch (HES): Synthesis, cytotoxicity and inclusion of anaesthetic actives
por: Markenstein, Lisa, et al.
Publicado: (2014)

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C(max))remain unaffected
por: Jungheinrich, C, et al.
Publicado: (2001)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
por: Costa, MG, et al.
Publicado: (2003)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma
por: Neff, ThA, et al.
Publicado: (2001)

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study
por: Grauer, MT, et al.
Publicado: (2001)

Hydroxyethyl starch for perioperative fluid management: a critical appraisal
por: Schmidt, André P., et al.
Publicado: (2023)

Probiotics in critical illness
por: Klarin, B, et al.
Publicado: (1999)

Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial
por: Wittbrodt, Piotr, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Hydroxyethyl starch in severe sepsis: end of starch era?
por: Estrada, Carlos A, et al.
Publicado: (2013)

Does discontinuation of the use of hydroxyethyl starches in the critically ill cardiac surgery patient have an impact on caloric intake?
por: Waele, E De, et al.
Publicado: (2015)

HES 130 kD, but not crystalloid volume support reduces leukocyte–endothelial cell interaction during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

G-CSF Administration after the Intraosseous Infusion of Hypertonic Hydroxyethyl Starches Accelerating Wound Healing Combined with Hemorrhagic Shock
por: Huang, Hong, et al.
Publicado: (2016)

Skeletal muscle strength in critically ill patients
por: Harris, ML, et al.
Publicado: (1999)

Adrenocortical function and outcome in critically ill patients
por: Bermejo, E, et al.
Publicado: (1998)

Hydroxyethyl starch - the importance of being earnest
por: Chappell, Daniel, et al.
Publicado: (2013)

Hydroxyethyl starch based smart nanomedicine
por: Wang, Huimin, et al.
Publicado: (2021)

Oxygen consumption in critically ill children
por: Sapiega, V, et al.
Publicado: (2002)

Terminal weaning in critically ill patients
por: Cerny, V, et al.
Publicado: (2002)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Pruritus: a clinical sign we can use to detect the vasodilating effect of vancomycin
por: Bertolissi, M, et al.
Publicado: (1999)

Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid-base status in the critically ill
por: Spoelstra–de Man, Angélique M. E., et al.
Publicado: (2017)

Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines
por: Ström, A, et al.
Publicado: (2000)

The effect of nutrition and severity of illness on blood vitamin concentrations in critically ill patients
por: Hill, SE, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_e59msjs3r1ma61b63btuf2l7jj